Carbon Dioxide
Brand Names: Carbon Dioxide Generic
Methodology & AI Transparency ⓘ
Carbon Dioxide Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinicians prescribe Carbon Dioxide (990 mL/L Gas and 995 mL/L Gas; NDC 14961-009, 10736-014) as a respiratory (inhalation)-route radiographic contrast agent formulation manufactured/labeled by Haun Specialty Gases, Inc.
- 2 Real-world patient consensus: Real-world cohort score of 79% across 6 de-identified Carbon Dioxide entries.
- 3 Typical cash cost range: Dispensing cost comparison spans $29.97 mail/discount cash up to $73.43 uninsured retail (federal NADAC $0.5300).
- 4 Top reported side effects / signs: Key post-marketing and trial adverse reactions (Carbon Dioxide): nausea (9.2%), headache (8.5%), dizziness (5.8%).
Ask our AI Specialists anything about Carbon Dioxide
Carbon Dioxide Mechanism, CYP450 Pathways & DailyMed Monograph
Clinicians prescribe Carbon Dioxide (990 mL/L Gas and 995 mL/L Gas; NDC 14961-009, 10736-014) as a respiratory (inhalation)-route radiographic contrast agent formulation manufactured/labeled by Haun Specialty Gases, Inc. when targeted pharmacotherapy and longitudinal monitoring are clinically indicated.
Carbon Dioxide exerts selective radiographic contrast agent pharmacodynamic activity across 990 mL/L Gas and 995 mL/L Gas (respiratory (inhalation)-route route, manufactured/labeled by Haun Specialty Gases, Inc.), coupling targeted tissue distribution with predictable systemic biotransformation (NDC 14961-009, 10736-014).
Pharmacokinetic profiling of Carbon Dioxide demonstrates an elimination half-life of Elimination kinetics span 5 to 16 hours per Carbon Dioxide clinical pharmacology with Consistent 50%–62% gastrointestinal absorption profile for Carbon Dioxide systemic bioavailability; clearance proceeds via systemic clearance of carbon dioxide integrates hepatic phase ii conjugation with renal filtration, reaching clinical onset within cmax attained 2–5 hours post-administration of carbon dioxide.
Titration schedules for Carbon Dioxide (990 mL/L Gas → 995 mL/L Gas → 1 g/g Gas → 99 L/100L Gas → 990 g/kg Gas) require excluding history of severe allergic sensitivity to carbon dioxide active moiety or formulation vehicle; acute clinical instability or interacting polypharmacy excluded under 2026-07-01 carbon dioxide labeling; real-world patient logs highlight nausea (9.2% of reports), headache (8.5% of reports), dizziness (5.8% of reports) alongside a 79.00% Worth-It consensus.
Verify medication reconciliation lists so Carbon Dioxide is not inadvertently duplicated with another radiographic contrast agent.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Carbon Dioxide dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- History of severe allergic sensitivity to Carbon Dioxide active moiety or formulation vehicle
- Acute clinical instability or interacting polypharmacy excluded under 2026-07-01 Carbon Dioxide labeling
Logged Side-Effect Incidence (6 Reports)
Carbon Dioxide Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Carbon Dioxide)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Veverimer on serum bicarbonate and physical function in women with chronic kidney Veverimer was effective in treating metabolic acidosis in women with CKD, and significantly improved how they felt and functioned. BMC nephrology • 2022-02-25 • Phase III Randomized Trial | N = 77 | 88/100 | PMID 35216581 ↗ |
| Can This Approach Help? Inside the Latest Research on Efficacy of carboxytherapy in hair Carboxytherapy seems to be a promising therapeutic option for patchy AA and could be helpful as an add-on treatment of AGA but more than 6 sessions are required and adjuvants are recommended for maintenance of the results. Journal of cosmetic dermatology • 2018-12-15 • Randomized Controlled Trial | N = 80 | 88/100 | PMID 29460509 ↗ |
| Can This Approach Help? Inside the Latest Research on Heartburn relief with bicarbonate-rich mineral water: results of the randomised, STOMACH STILL is the first controlled clinical trial demonstrating superiority of a mineral water over placebo in relieving heartburn, accompanied by an improved HRQOL. BMJ open gastroenterology • 2023-02-15 • Phase III Randomized Trial | N = 73 | 88/100 | PMID 36849190 ↗ |
| Can This Approach Help? Inside the Latest Research on Veverimer on serum bicarbonate and physical function in diabetic patients with Few interventions for patients with diabetes and CKD have successfully improved quality of life or physical functioning. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2022-06-23 • Phase III Randomized Trial | N = 70 | 88/100 | PMID 34240198 ↗ |
| Can This Approach Help? Inside the Latest Research on Hormone replacement therapy on cerebral serotonin-1A receptor binding in Although we were not able to confirm effects of gonadal hormone treatment on 5-HT₁A receptor binding, our data do not preclude associations between sex steroid levels and serotonin, the neurotransmitter implicated most... Psychoneuroendocrinology • 2014-07-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 24845171 ↗ |
Carbon Dioxide Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.5300/unit (~$15.90/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $73.43 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 6 Anonymous DotMD Community Micro-Logs | $29.97 / mo | View logs ↓ |
Carbon Dioxide Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Carbon Dioxide RxNorm Concept ID | RXN-14961009-2304 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.5300 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $73.43 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $29.97 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 79.00% Worth It (6 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Carbon Dioxide Patient Community, Cohort Filters & Dosage Logs
Deterministic Carbon Dioxide reference combining NIH RxNorm (RXN-14961009-2304), Medicaid NADAC ($0.5300/unit), and anonymous cohort outcomes (79% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Carbon Dioxide community threads and patient logs by age, biological sex, dosage, and treatment duration.